Scribe Therapeutics Inc. (SCTX) Financials
SCTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 57.9 million | 222.8 million |
| March 31, 2026 | 65.2 million | 223.9 million |
| June 30, 2025 | ? | ? |
| March 31, 2025 | ? | ? |
SCTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -5.3 million | 227000 |
| March 31, 2026 | -7.6 million | 2.0 million |
| June 30, 2025 | -7.1 million | 676000 |
| March 31, 2025 | -14.1 million | 671000 |
SCTX Net Income
No data available :(
SCTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | - | - | 5.5 million |
| March 31, 2026 | - | - | 5.8 million |
| June 30, 2025 | - | - | - |
| March 31, 2025 | - | - | - |
SCTX Shares Outstanding
SCTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 10000 | 8.8 million | 2.5 million | - |
| March 31, 2026 | 17000 | 11.3 million | 3.4 million | - |
| June 30, 2025 | 439000 | 13.9 million | 2.6 million | - |
| March 31, 2025 | 491000 | 16.0 million | 6.7 million | - |
SCTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.9 million | - |
| March 31, 2026 | 2.2 million | - |
| June 30, 2025 | 4.9 million | - |
| March 31, 2025 | 17.1 million | - |
SCTX
Price: $20.08
52 week price:
Earnings Per Share: -1.83 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 292.4 million